Braeburn

Braeburn Pharmaceuticals is an American pharmaceutical R&D company that develops long-acting medications for treating adult opioid use disorder (OUD). Their product types include long-acting injectables and implantable formulations, providing various solutions for chronic conditions such as severe neurological and psychiatric disorders (including addiction, pain, and schizophrenia).